Steven Cohen Entera Bio Ltd. Put Options Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ENTX
# of Institutions
22Shares Held
10.2MCall Options Held
31KPut Options Held
100-
Knoll Capital Management, LLC Miami, FL5.88MShares$11.8 Million6.68% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY599KShares$1.2 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT440KShares$879,2640.1% of portfolio
-
Northern Trust Corp Chicago, IL199KShares$397,6620.0% of portfolio
-
Perigon Wealth Management, LLC San Francisco, CA146KShares$291,6860.01% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $57.6M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...